The ingredient, SelectSIEVE OptiChol, comprises standardized polyphenols from olive.
Photo © iStockphoto.com
Roelmi HPC (Milan) will showcase its new healthy-cholesterol ingredient, SelectSIEVE OptiChol, at the SupplySide West trade show, taking place October 31 to November 4, 2022, in Las Vegas (Booth 3432).
SelectSIEVE OptiChol comprises standardized polyphenols from olive (Olea europaea). The company says SelectSIEVE OptiChol has been clinically shown “to modulate the whole lipidemic profile and related dyslipidemia parameters by downregulating total cholesterol, LDL cholesterol, and non-HDL cholesterol, together with an increase of HDL cholesterol. It also demonstrated activity in reducing other risk factors of cardiometabolic disease by improving systolic blood pressure and pulses, reducing fasting plasma glycaemia, and decreasing serum uric acid.”
It continues: “Derived from a circular economy involving only olive byproducts of the variety Coratina, an Apulian native cultivar, the ingredient is particularly rich in hydroxytyrosol, widely described in literature and recognized by EFSA for reducing oxidative stress, being active in lipid metabolism, and protecting body cells or LDL from oxidative damages.”
FDA and FTC issue more warning letters to copycat delta-8 THC food products
July 16th 2024The U.S. Food and Drug Administration and Federal Trade Commission have jointly issued warning letters to five companies for selling copycat food products containing delta-8 THC in violation of the Federal Food Drug and Cosmetic Act.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.